CHM-2133-P

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCHM-2133-P
Drug Alias NameIGF-1R modulator (China Medical University)insulin like growth factor-1 receptor modulator (China Medical University)insulin like growth factor-1 receptor modulator (Efficient Pharma Management Corporate)IGF-1R modulator (Efficient Pharma Management Corporate)CHM-2133-P
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor I receptor modulators
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChina Medical University, Taiwan
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEfficient Pharma Management CorpTairx IncChina Medical University, Taiwan
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A